Another research indicated the AIS patients receiving IV-tPA within 60 min of stroke symptom onset have a higher complete recanalization rate, showed improvement in the nervous system, and obtained better mRS scores and lower mortality at 90-day follow-up compared to the patients receiving administration after 60 min of onset (21). The gene discussed is PLAT; the disease is androgen insensitivity syndrome.